Correction: Mapatumumab, a fully human agonistic monoclonal antibody that targets TRAIL-R1, in combination with gemcitabine and cisplatin: A phase I study (Clinical Cancer Research (2009) 15, (5584-5590))

C. H. Mom, J. Verweij, C. N A M Oldenhuis

Research output: Contribution to journalComment/Letter to the editorAcademic

Original languageEnglish
Number of pages1
JournalClinical Cancer Research
Issue number21
Publication statusPublished - 1 Nov 2009

Cite this